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which the outer pie-charts show the results with 3%/3mm and 
the inner pie-charts illustrate results with 2%/2mm.  
 
Conclusion: The results showed that Octavius 4D phantom, 
with 2D-Array seven29, can be an adequate verification 
system both for simple and more complex cases. Additionally, 
the merge capability of the VeriSoft software, which can 
increase spatial resolution, is a useful tool for more complex 
VMAT plans. 
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Purpose or Objective: The aim of this study is to utilize the 
EGSnrc based Monte Carlo code in order to assess the 
EclipseTM (AAA) calculated dose estimation at the Water-
Lung (WL) interfaces when irradiated by 6 MV photon beams 
at 15˚ , 30˚, 45˚ and 60˚ wedge angles and multiple field 
sizes of 5 × 5 cm2, 10 × 10 cm2 and 20 × 20 cm2. 
 
Material and Methods: EGSnrc sub codes are used for Monte 
Carlo dose simulation. BEAMnrc is used to simulate the linear 
accelerator head, whereas DOSXYZnrc is employed to 
perform phantom dose estimation. For simulating dynamic 
wedges the BEAMnrc component module DYNJAWS was 
employed. Phantom geometry includes a 10 cm layer of lung 
(r=0.250 g/cc) sandwiched between 5 cm and 10 cm water 
layers. Doses were calculated in exactly the same geometry 
and same density distribution by Monte Carlo and AAA 
algorithm. The overall dimension of the phantom was 30 cm × 
30 cm × 25 cm. A 5 mm grid size (voxel width) along depth 
was used for calculating PDDs. The nominal source to surface 
distance (SSD) of 100 cm was used in both setups. 
 
Results: The dose perturbation effect was found to be field 
size dependent. It increases with decreasing field size. No 
clear dependence for the wedge angles was observed. No 
dose deviation between AAA and EGSnrc was observed at the 
water→tissue interface. However a lower dose in the lung 
was estimated by AAA. Whereas at the lung→tissue junction 
a highest dose discrepancy was observed by AAA, estimating 
higher dose towards the water layer. 
 
 
 
Conclusion: We have demonstrated the limitation of AAA in 
dose calculation at the water-tissue-water interfaces for four 
wedge angles. There was no significant wedge angle 
dependence on the dose perturbation. However an increase 
in perturbation was observed with decreasing field sizes for 
all angles. 
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Purpose or Objective: Modern dose calculation algorithms 
only model absence of lateral charged particle equilibrium to 
a limited extent. The resulting uncertainties are largest in 
strongly heterogeneous regions, such as the thorax, and will 
potentially increase in deep inspiration breath hold (DIBH) 
due to decreased lung tissue density. 
 
Material and Methods: Ten patients with stage I and ten with 
stage III lung cancer were included. For all patients, a plan in 
free breathing (FB, based on midventilation) and in DIBH 
were made with the clinically used Anysotropic Analytical 
Algorihtm (AAA). Stage I disease was treated stereotactically 
(SBRT) using 3D conformal technique (9-10 fields), 45 Gy in 3 
fractions, prescribed to 95% isodose covering 95% of PTV and 
aiming for 140% dose in the isocenter. Stage III disease was 
treated with VMAT (2 arcs), 66 Gy in 33 fractions, prescribed 
to mean PTV dose. 6 MV energy was used for all plans. 
Calculation grid size was 1 mm for stage I and 2.5 mm for 
stage III. Plans were recalculated in more advanced Acuros 
with same MU as in AAA.  
Plans were compared for target coverage (GTV, CTV, PTV), 
estimated from mean dose, near minimum (D98) and near 
maximum doses (D2), as defined in ICRU 83, and for SBRT 
also for the fraction of PTV covered by prescription dose 
(V45). Organs at risk parameter for stage I was fraction of 
lung receiving more than 13 Gy (V13), and for stage III, mean 
lung dose, lung V5, V20 and V40 and also mean heart dose 
and heart V50. 
 
Results: In DIBH, lung density decreased by median 6% (47.6 
HU) reduction for stage I and 12% (88.5 HU) for stage III.  
In stage III, AAA overestimated mean target doses for FB and 
DIBH GTV and DIBH CTV (by median <0.8 Gy; p<0.05 Wilcoxon 
signed-rank test) and had no impact on D2. AAA 
overestimated D98 by median ~1 Gy for GTV and CTV 
(p<0.05), and more for PTV (by 1.5 Gy and 2.1 Gy, in FB and 
DIBH respectively; p<0.01).  
In stage I, AAA had similar effect on GTV as in stage III. 
However, differences between the two algorithms were 
substantial for PTV and more pronounced in DIBH: AAA 
overestimated all PTV parameters (p<0.01), with largest 
impact on V45 (up to 41.4% in FB and 66.3% in DIBH), while 
mean dose and D98 were overestimated by 2.0 Gy and 2.3 Gy 
in FB and 3.1 Gy and 4.0 Gy in DIBH. These clinically relevant 
differences may be a combination of small targets and large 
dose gradients in the SBRT treated volume.  
Lung and heart dose parameters decreased in DIBH compared 
to FB, but were similar for both algorithms and both disease 
stages (median differences ±0.3% for volumetric parameters 
and ±0.2 Gy for mean doses). More details on actual 
dosimetric parameters are presented in the table. 
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Conclusion: In VMAT of stage III lung cancer, AAA precision is 
adequate even in DIBH. In SBRT of stage I lung cancer, AAA 
overestimates target coverage, especially in DIBH. However, 
changing to the more correct Acuros for stage I SBRT may 
potentially facilitate a change in clinically prescribed dose. 
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Purpose or Objective: Monte Carlo-based treatment planning 
systems (TPS) are becoming as standard in radiation therapy, 
performing and reporting calculations in terms of the 
absorbed dose to medium (Dm). In addition, patient-specific 
QA techniques for IMRT and VMAT treatments have recently 
evolved from traditional dose distribution comparisons 
between calculations and measurements to 3D dose 
calculation and reconstruction on patient anatomy, enabling 
DVH-based comparisons. In order to perform previous 
calculations, commercial solutions have introduced collapsed 
cone algorithms, based in dose engines that report 
calculations in terms of the absorbed dose to water (Dw). 
Differences between Dm and Dw can lead to significant 
discrepancies in DVH comparisons. This study reports the 
discrepancies between Dm and Dw calculations applied to 
patient-specific prostate VMAT treatments. 
 
Material and Methods: VMAT treatments were delivered with 
a 6 MV Synergy (Elekta) machine. Plans were generated with 
Monaco 3.1 (Elekta). 3D dose calculations were performed 
with two systems: Mobius3D (Mobius Medical Systems) (M3D) 
and COMPASS (IBA Dosimetry) (CC). In addition, the second 
one is capable of reconstructing the dose from measurements 
(CR). Forty prostate treatments were analyzed, taking 10 
from each usual staging (hig-, intermediate- and low-risk) 
and 10 prostate bed treatments after prostatectomy. 
Parameters analyzed for PTVs were taken from ICRU-83 
recommendations. Normal tissue parameters were evaluated 
using QUANTEC constraints for rectum, bladder and femoral 
heads. 
 
Results: Mean differences for PTVs parameters with Dm 
calculations were -0.61%±0.71%, -0.04%±1.49% and 
0.08%±1.52% for CC, CR and M3D, respectively. For PTVs 
parameters with Dm calculations discrepancies were -
0.22%±0.50%, 0.36%±1.27% and 0.47%±1.28%. Mean 
differences for normal tissue and CC, CR and M3D 
comparisons, respectively, were: 0.38%±0.74%, 2.94%±1.31% 
and 2.12%±1.31% for Dm, and 0.38%±0.54%, 2.94%±1.20% and 
2.12%±1.40% for Dw in rectum; 0.16%±1.06%, -1.00%±1.11% 
and 0.16%±1.45% for Dm, and 0.10%±0.58%, -1.06%±0.78% and 
0.10%±1.12% for Dw in bladder; -1.42%±0.83%, -1.03%±2.04% 
and -1.57%±1.77% for Dm, and 0.28%±2.01%, 0.88%±2.45% and 
-0.07%±2.62% for Dw in femoral heads. 
 
Conclusion: Results were slightly better for Dw in femoral 
heads than Dm calculations. Remaining data were similar for 
both Dm and Dw. According AAPM TG-105, QA comparisons 
should be performed with the same criterion (Dw). 
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Purpose or Objective: If rectal balloon were not used in 
rectum cancer treatment, there is a lack of reproducibility of 
rectum shape on each treatment and irregularly inserted air 
inside the rectum cause inhomogeneity of density with 
surrounding tissue, which could be resulted in uncertainty of 
dose delivery. In this research, we estimated the accuracy of 
TPS(Treatment Planning System) dose calculation and actual 
dose, and compared dose distribution when homogeneity of 
rectum and surrounding tissue increases as inner materials of 
rectal balloon changes. 
 
Material and Methods: Cylindrical PMMA RPLGD phantom was 
used to measure dose at rectal wall and Air, water and PMMA 
were used as inner balloon materials. Total 12 plans(prostate 
and rectum cancer 3D-CRT(3 Dimensional Conformal 
Radiation Therapy) and IMRT(Intensity Modulated Radiation 
Therapy) plans with air, water, and PMMA balloons) were 
made using Varian Eclipse ver.8.9 to estimate influence of 
rectal balloon material on dose distribution. Each 16 glass 
dosimeters were located at rectum wall so that the point 
doses were compared with TPS. 
 
Results: As Homogeneity increase, Dose distribution was 
improved. As CT HU value of inner balloon material increase 
from 0(air) to 1000(water) and 1120(PMMA), Homogeneity 
Index(HI) and Conformity Index(CI) were increased about 20% 
and 5%, respectively. And considerable difference, between 
TPS and RPLGD reading, was measured with air balloon when 
water and PMMA balloons had less variation. 
 
 
 
